INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,000 | -60.0% | 486 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 486 | -21.9% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 622 | -26.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 840 | +32.1% | 0.00% | – |
Q4 2017 | $6,000 | -33.3% | 636 | -32.5% | 0.00% | -100.0% |
Q3 2017 | $9,000 | -30.8% | 942 | -9.8% | 0.00% | 0.0% |
Q2 2017 | $13,000 | -45.8% | 1,044 | -59.8% | 0.00% | -66.7% |
Q4 2016 | $24,000 | -52.0% | 2,600 | -38.1% | 0.00% | -40.0% |
Q3 2016 | $50,000 | -16.7% | 4,200 | +100.0% | 0.01% | -44.4% |
Q4 2015 | $60,000 | +62.2% | 2,100 | +61.5% | 0.01% | +80.0% |
Q3 2015 | $37,000 | -50.7% | 1,300 | -38.1% | 0.01% | -50.0% |
Q2 2015 | $75,000 | +59.6% | 2,100 | +162.5% | 0.01% | +42.9% |
Q1 2015 | $47,000 | -67.1% | 800 | -76.5% | 0.01% | -66.7% |
Q4 2014 | $143,000 | +8.3% | 3,400 | 0.0% | 0.02% | +10.5% |
Q3 2014 | $132,000 | -15.4% | 3,400 | -32.0% | 0.02% | -9.5% |
Q2 2014 | $156,000 | – | 5,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |